149 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 3 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
GABRG2Gamma-aminobutyric acid type A receptor gamma2 subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
GABRR1Gamma-aminobutyric acid type A receptor rho1 subunitFDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GHRHRGrowth hormone releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Not detected
GLP1RGlucagon like peptide 1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
GLRA1Glycine receptor alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
GLRA3Glycine receptor alpha 3FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
GLRBGlycine receptor betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GNRHRGonadotropin releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
GRIN1Glutamate ionotropic receptor NMDA type subunit 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
Tissue enriched
GRIN2CGlutamate ionotropic receptor NMDA type subunit 2CFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
GUCY2CGuanylate cyclase 2CDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesGroup enriched
HBA1Hemoglobin subunit alpha 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBA2Hemoglobin subunit alpha 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBBHemoglobin subunit betaDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
HTR1B5-hydroxytryptamine receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR2B5-hydroxytryptamine receptor 2BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR3A5-hydroxytryptamine receptor 3AFDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HTR3D5-hydroxytryptamine receptor 3DFDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
ITGAVIntegrin subunit alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Focal adhesion sites
Cytosol
Expressed in all
ITGB1Integrin subunit beta 1Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites
Expressed in all
KCNA2Potassium voltage-gated channel subfamily A member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel subfamily A member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK3Potassium two pore domain channel subfamily K member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium two pore domain channel subfamily K member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium voltage-gated channel subfamily Q member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
MC2RMelanocortin 2 receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
MS4A1Membrane spanning 4-domains A1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneGroup enriched
MS4A2Membrane spanning 4-domains A2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
MTNR1AMelatonin receptor 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
NPR2Natriuretic peptide receptor 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
NR1H4Nuclear receptor subfamily 1 group H member 4Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Transporters
NucleoplasmTissue enhanced
OPRM1Opioid receptor mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
P2RX4Purinergic receptor P2X 4FDA approved drug targets
Predicted membrane proteins
Transporters
Actin filaments
Cytosol
Mixed
P2RY2Purinergic receptor P2Y2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolTissue enhanced
PTGER1Prostaglandin E receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
« prev | Page of 3 | next »